Biofilm Production by Candida Species and Inadequate Antifungal Therapy as Predictors of Mortality for Patients with Candidemia
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Nosocomial Candida bloodstream infections rank among infections with highest mortality rates. A retrospective cohort analysis was conducted at Catholic University Hospital to estimate the risk factors for mortality of patients with candidemia. We reviewed records for patients with a Candida bloodstream infection over a 5-year period (January 2000 through December 2004). Two hundred ninety-four patients (42.1% male; mean age ± standard deviation, 65 ± 12 years) were studied. Patients most commonly were admitted with a surgical diagnosis (162 patients [55.1%]), had a central venous catheter (213 [72.4%]), cancer (118 [40.1%]), or diabetes (58 [19.7%]). One hundred fifty-four (52.3%) patients died within 30 days. Of 294 patients, 168 (57.1%) were infected by Candida albicans , 64 (21.7%) by Candida parapsilosis , 28 (9.5%) by Candida tropicalis , and 26 (8.8%) by Candida glabrata . When fungal isolates were tested for biofilm formation capacity, biofilm production was most commonly observed for isolates of C. tropicalis (20 of 28 patients [71.4%]), followed by C. glabrata (6 of 26 [23.1%]), C. albicans (38 of 168 [22.6%]), and C. parapsilosis (14 of 64 [21.8%]). Multivariable analysis identified inadequate antifungal therapy (odds ratio [OR], 2.35; 95% confidence interval [95% CI], 1.09 to 5.10; P = 0.03), infection with overall biofilm-forming Candida species (OR, 2.33; 95% CI, 1.26 to 4.30; P = 0.007), and Acute Physiology and Chronic Health Evaluation III scores (OR, 1.03; 95% CI, 1.01 to 1.15; P < 0.001) as independent predictors of mortality. Notably, if mortality was analyzed according to the different biofilm-forming Candida species studied, only infections caused by C. albicans ( P < 0.001) and C. parapsilosis ( P = 0.003) correlated with increased mortality. Together with well-established factors, Candida biofilm production was therefore shown to be associated with greater mortality of patients with candidemia, probably by preventing complete organism eradication from the blood.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The multivariate analysis identified three factors associated with mortality: inadequate antifungal therapy, infection with biofilm-forming Candida species, and Apache III score.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,411
CDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 1×
“Nosocomial Candida bloodstream infections (BSIs), with an estimated annual incidence in the United States of 6 to 10 candidemia episodes per 100,000 population, have become a considerable public health concern (24, 25, 29).”
BackgroundCDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770
The APACHE III Prognostic System
Knaus, W. A., Wagner, D. P., Draper, E. A., Zimmerman, J. E., Bergner, M., Bastos, P. G., Sirio, C. A., Murphy, D. J., Lotring, T., Damiano, A., et al. (1991) · Chest · doi:10.1378/chest.100.6.1619 · Cited by 3,439
The APACHE III Prognostic System
Teres, D., & Lemeshow, S. (1992) · Chest · doi:10.1378/chest.102.6.1919b · Cited by 2,880
Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 5×
“Of 294 patients with Candida BSIs (mean age standard deviation, 65 12 years; 42.1% male), 262 cases (89.1”
BackgroundInfluentialFriedman, N. D., Kaye, K. S., Stout, J. E., McGarry, S. A., Trivette, S. L., Briggs, J. P., Lamm, W., Clark, C., MacFarquhar, J., Walton, A. L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-10-200211190-00007 · Cited by 1,668
Manual of Clinical Microbiology, 7th ed.
Balows, A. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(99)00102-9 · Cited by 1,613
Cited by
Items 101–200 of 416
Paiva, L. C. F., Vidigal, P. G., Donatti, L., Svidzinski, T. I. E., & Consolaro, M. E. L. (2012) · Micron · doi:10.1016/j.micron.2011.09.013 · Cited by 55
Gaining Insights from Candida Biofilm Heterogeneity: One Size Does Not Fit All
Kean, R., Delaney, C., Rajendran, R., Sherry, L., Metcalfe, R., Thomas, R., McLean, W., Williams, C., & Ramage, G. (2018) · Journal of Fungi · doi:10.3390/jof4010012 · Cited by 55
Liposomal Amphotericin B Displays Rapid Dose-Dependent Activity against Candida albicans Biofilms
Ramage, G., Jose, A., Sherry, L., Lappin, D. F., Jones, B., & Williams, C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02344-12 · Cited by 55
Mortality in patients with early- or late-onset candidaemia
Rosa, F. G. D., Trecarichi, E. M., Montrucchio, C., Losito, A. R., Raviolo, S., Posteraro, B., Corcione, S., Giambenedetto, S. D., Fossati, L., Sanguinetti, M., et al. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks480 · Cited by 58
Self-citationSherry, L., Jose, A., Murray, C. A., Williams, C., Jones, B., Millington, O. R., Bagg, J., & Ramage, G. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00116 · Cited by 55
Invasive Fungal Infections in High-Risk Patients: Report from TIMM-8 2017
Pagano, L., & Mayor, S. (2018) · Future Science OA · doi:10.4155/fsoa-2018-0019 · Cited by 55
Kulig, K., Karnas, E., Woźnicka, O., Kuleta, P., Zuba‐Surma, E. K., Pyza, E., Osyczka, A., Kozik, A., Rąpała‐Kozik, M., & Karkowska‐Kuleta, J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.879237 · Cited by 54
Tumbarello, M., Sanguinetti, M., Trecarichi, E. M., La Sorda, M., Rossi, M., de Carolis, E., de Gaetano Donati, K., Fadda, G., Cauda, R., & Posteraro, B. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn381 · Cited by 53
Self-citationKovács, R., Bozó, A., Gesztelyi, R., Domán, M., Kardos, G., Nagy, F., Tóth, Z., & Majoros, L. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.01.007 · Cited by 53
Candida parapsilosis Biofilm Identification by Raman Spectroscopy
Samek, O., Rebrošová, K., Bernatová, S., Ježek, J., Krzyžánek, V., Šiler, M., Zemánek, P., Růžička, F., Holá, V., & Mahelová, M. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151223924 · Cited by 52
Role of Antifungal Combinations in Difficult to Treat Candida Infections
Vitale, R. G. (2021) · Journal of Fungi · doi:10.3390/jof7090731 · Cited by 52
Biofilm Formation by Pseudallescheria/Scedosporium Species: A Comparative Study
Rollin‐Pinheiro, R., de Meirelles, J. V., Vila, T. V. M., Fonseca, B. B., Alves, V., Frasés, S., Rozental, S., & Barreto‐Bergter, E. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01568 · Cited by 51
Rishpana, M. S., & Kabbin, J. S. (2015) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2015/13910.6690 · Cited by 51
Our current clinical understanding of Candida biofilms: where are we two decades on?
Ramage, G., Borghi, E., Rodrigues, C. F., Kean, R., Williams, C., & Lopez-Ribot, J. L. (2023) · Apmis · doi:10.1111/apm.13310 · Cited by 51
Savage, R. D., Fowler, R. A., Rishu, A. H., Bagshaw, S. M., Cook, D., Dodek, P., Hall, R., Kumar, A., Lamontagne, F., Lauzier, F., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154944 · Cited by 49
Candidaemia in Patients with an Inserted Medical Device
Cauda, R. (2009) · Drugs · doi:10.2165/11315520-000000000-00000 · Cited by 48
Self-citationIntegrating Candida albicans metabolism with biofilm heterogeneity by transcriptome mapping
Rajendran, R., May, A., Sherry, L., Kean, R., Williams, C., Jones, B. L., Burgess, K. V., Heringa, J., Abeln, S., Brandt, B. W., et al. (2016) · Scientific Reports · doi:10.1038/srep35436 · Cited by 48
Fungal infections in the ICU: advances in treatment and diagnosis
PASCALE, G. D., & Tumbarello, M. (2015) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000230 · Cited by 47
Self-citationTascini, C., Sozio, E., Corte, L., Sbrana, F., Scarparo, C., Ripoli, A., Bertolino, G., Merelli, M., Tagliaferri, E., Corcione, A., et al. (2017) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2017.1384956 · Cited by 47
Salari, S., Seddighi, N. S., & Almani, P. G. N. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2018.02.007 · Cited by 47
Candida/Candida biofilms. First description of dual-species Candida albicans/C. rugosa biofilm
Martins, C. H. G., Pires, R. H., Cunha, A. O., Pereira, C. A., Singulani, J. D. L., Abrão, F., de Moraes, T., & Mendes‐Giannini, M. J. S. (2016) · Fungal Biology · doi:10.1016/j.funbio.2016.01.013 · Cited by 46
Watamoto, T., Samaranayake, L. P., Egusa, H., Yatani, H., & Seneviratne, C. J. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.030692-0 · Cited by 45
Epidemiology of Candida isolates from Intensive Care Units in Colombia from 2010 to 2013
Motoa, G., Muñoz, J. S., Oñate, J., Pallares, C., Hernández, C., & Villegas, M. V. (2016) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2016.02.006 · Cited by 45
Fungal biofilms: From bench to bedside.
Rio-Valencia, J. C. D., Asensi-Diez, R., Madera-Pajin, R., Yunquera-Romero, L., & Muñoz-Castillo, I. (2018) · PubMed Central · Cited by 45
Identification of yeast in chronic wounds using new pathogen-detection technologies
Leake, J. L., Dowd, S. E., Wolcott, R. D., Zischkau, A. M., & Sun, Y. (2009) · Journal of Wound Care · doi:10.12968/jowc.2009.18.3.39810 · Cited by 44
Borecká, S., & Bujdáková, H. (2008) · Canadian Journal of Microbiology · doi:10.1139/w08-060 · Cited by 44
Role of SFP1 in the Regulation of Candida albicans Biofilm Formation
Chen, H.-F., & Lan, C.-Y. (2015) · PLOS ONE · doi:10.1371/journal.pone.0129903 · Cited by 43
Brunetti, G., Navazio, A. S., Giuliani, A., Giordano, A., Proli, E. M., Antonelli, G., & Raponi, G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224678 · Cited by 43
Candidemia in the 21st Century
Chang, A., Neofytos, D., & Horn, D. (2008) · Future Microbiology · doi:10.2217/17460913.3.4.463 · Cited by 44
Ambroxol influences voriconazole resistance of Candida parapsilosis biofilm
Pulcrano, G., Panellis, D., Domenico, G., Rossano, F., & Catania, M. R. (2012) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2012.00792.x · Cited by 41
Jahanshiri, Z., Manifar, S., Moosa, H., Asghari-Paskiabi, F., Mahmoodzadeh, H., Shams‐Ghahfarokhi, M., & Razzaghi‐Abyaneh, M. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2018.01.001 · Cited by 41
Zuo, X., Liu, Y., Cai, X., Zhan, L., & Hu, K. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23738 · Cited by 41
Antifungal Activity against Candida Biofilms
Íñigo, M., Pemán, J., & del Pozo, J. L. (2012) · The International Journal of Artificial Organs · doi:10.5301/ijao.5000170 · Cited by 40
Distorted Gold(I)–Phosphine Complexes as Antifungal Agents
Dennis, E. K., Kim, J. H., Parkin, S., Awuah, S. G., & Garneau‐Tsodikova, S. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01436 · Cited by 39
Baracaldo-Santamaría, D., Cala-García, J., Medina-Rincón, G. J., Rojas-Rodríguez, L. C., & Calderón‐Ospina, C. (2022) · Antibiotics · doi:10.3390/antibiotics11050645 · Cited by 39
Moralez, A. T. P., de França, E. J. G., Furlaneto-Maia, L., Quesada, R. M. B., & Furlaneto, M. C. (2013) · Medical Mycology · doi:10.3109/13693786.2013.825822 · Cited by 40
Barbedo, L. S., Vaz, C., Pais, C., Figueiredo‐Carvalho, M. H. G., Muniz, M. D. M., Zancopé‐Oliveira, R. M., & Sampaio, P. (2014) · Journal of Medical Microbiology · doi:10.1099/jmm.0.080655-0 · Cited by 38
Study of Antifungal Susceptibility, Virulence Genes and Biofilm Formation in Candida albicans
Shrief, R., Zaki, M. E. S., El-Sehsah, E. M., Essa, S. G., & Mofreh, M. (2019) · The Open Microbiology Journal · doi:10.2174/1874285801913010241 · Cited by 37
Sasani, E., Khodavaisy, S., Rezaie, S., Salehi, M., & Yadegari, M. H. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104889 · Cited by 38
Evaluation of Droplet Digital PCR Assay for the Diagnosis of Candidemia in Blood Samples
Chen, B., Xie, Y., Zhang, N., Li, W., Liu, C., Li, D., Bian, S., Jiang, Y., Yang, Z., Li, R., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.700008 · Cited by 37
Management of Candida Biofilms: State Of Knowledge and New Options for Prevention and Eradication
Bujdáková, H. (2016) · Future Microbiology · doi:10.2217/fmb.15.139 · Cited by 37
INCREASE IN CANDIDA PARAPSILOSIS CANDIDEMIA IN CANCER PATIENTS
Sun, M., Chen, C., Xiao, W., Chang, Y., Liu, C., & Xu, Q. (2019) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2019.012 · Cited by 37
Agnelli, C., Valerio, M., Bouza, E., Guinea, J., Sukiennik, T., Guimarães, T., Queiroz-Telles, F., Muñoz, P., & Colombo, A. L. (2022) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2021.100117 · Cited by 36
Molecular Diagnosis of Yeast Infections
White, P. L., Price, J. S., Cordey, A., & Backx, M. (2021) · Current Fungal Infection Reports · doi:10.1007/s12281-021-00421-x · Cited by 36
Seidler, M., Salvenmoser, S., & Müller, F.-M. C. (2010) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2010.00618.x · Cited by 35
Blanco, M. T., Enciso, B. S., Lucio, L., Blanco, J., Pérez-Giraldo, C., & Gómez-García, A. C. (2010) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2010.09.001 · Cited by 35
Strategies in the Discovery of Novel Antifungal Scaffolds
Liu, N., Wang, C., Su, H., Zhang, W., & Sheng, C. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0020 · Cited by 34
O’Donnell, L. E., Alalwan, H. K. A., Kean, R., Calvert, G., Nile, C. J., Lappin, D. F., Robertson, D. P., Williams, C., Ramage, G., & Sherry, L. (2016) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000419 · Cited by 33
Knoll, M. A., Ulmer, H., & Lass‐Flörl, C. (2021) · Journal of Fungi · doi:10.3390/jof7010063 · Cited by 33
Katragkou, A., Roilides, E., & Walsh, T. J. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ746 · Cited by 35
Pongrácz, J., Benedek, K., Juhász, E., Iván, M., & Kristóf, K. (2015) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000207 · Cited by 33
Genetic determinants of virulence – Candida parapsilosis
Singaravelu, K., Gácser, A., & Nosanchuk, J. D. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.09.018 · Cited by 32
de França, E. J. G., Andrade, C. G. T. J., Furlaneto-Maia, L., Serpa, R., de Oliveira, M. T., Quesada, R. M. B., & Furlaneto, M. C. (2011) · Micron · doi:10.1016/j.micron.2011.03.008 · Cited by 37
Hu, B., Du, Z., Kang, Y., Zang, B., Cui, W., Qin, B., Fang, Q., Qiu, H., & Li, J. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0594-0 · Cited by 32
Tay, S. T., Abidin, I. A. Z., Hassan, H. H., & Ng, K. P. (2011) · Medical Mycology · doi:10.3109/13693786.2010.551424 · Cited by 34
Biofilms and beyond: Expanding echinocandin utility
Larkin, E. L., Dharmaiah, S., & Ghannoum, M. A. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx451 · Cited by 31
In-vivo Candida biofilms in scanning electron microscopy
Paulitsch, A. H., Willinger, B., Zsalatz, B., Stabentheiner, E., Marth, E., & Buzina, W. (2009) · Medical Mycology · doi:10.3109/13693780802635237 · Cited by 31
Fais, R., Luca, M. D., Rizzato, C., Morici, P., Bottai, D., Tavanti, A., & Lupetti, A. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02218 · Cited by 31
Voriconazole inhibits biofilm formation in different species of the genus Candida
Valentín, A., Cantón, R., Pemán, J., & Martinez, J. P. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks242 · Cited by 31
Lovero, G., Borghi, E., Balbino, S., Cirasola, D., Giglio, O. D., Perdoni, F., Caggiano, G., Morace, G., & Montagna, M. T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150218 · Cited by 31
Guembe, M., Alonso, B., Lucio, J., Pérez-Granda, M. J., Cruces, R., Sánchez‐Carrillo, C., Fernández‐Cruz, A., & Bouza, E. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.10.018 · Cited by 31
Agnelli, C., Guimarães, T., Sukiennik, T., Lima, P. R. P., Salles, M. J. C., Breda, G. L., Queiroz‐Telles, F., Magri, M. M. C., Mendes, A. V. A., Camargo, L. F. A., et al. (2023) · Journal of Fungi · doi:10.3390/jof9040468 · Cited by 30
Candida species biofilm and Candida albicans ALS3 polymorphisms in clinical isolates
Bruder-Nascimento, A., Camargo, C. H., Mondelli, A. L., Sugizaki, M. F., Sadatsune, T., & Bagagli, E. (2014) · Brazilian Journal of Microbiology · doi:10.1590/s1517-83822014000400030 · Cited by 30
CandidaSpecies Isolated from Urban Bats of Londrina‐Paraná, Brazil and their Potential Virulence
Botelho, N., de Paula, S. B., Panagio, L. A., Pinge‐Filho, P., Yamauchi, L. M., & Yamada‐Ogatta, S. F. (2011) · Zoonoses and Public Health · doi:10.1111/j.1863-2378.2011.01410.x · Cited by 30
Clinical impact of Candida spp. biofilm production in a cohort of patients with candidemia
Monfredini, P. M., Souza, A. C. R., Cavalheiro, R. P., Siqueira, R. A., & Colombo, A. L. (2017) · Medical Mycology · doi:10.1093/mmy/myx133 · Cited by 30
Microbiota-driven interleukin-17 production provides immune protection against invasive candidiasis
Li, M., Li, C., Wu, X., Chen, T., Ren, L., Xu, B., & Cao, J. (2020) · Critical Care · doi:10.1186/s13054-020-02977-5 · Cited by 29
Antifungal and Antibiofilm Activity of Colombian Essential Oils against Different Candida Strains
Ruiz-Duran, J., Torres, R. G., Stashenko, E. E., & Ortíz, C. (2023) · Antibiotics · doi:10.3390/antibiotics12040668 · Cited by 29
Low but Sufficient Anidulafungin Exposure in Critically Ill Patients
van Wanrooy, M. J. P., Rodgers, M. G. G., Uges, D. R. A., Arends, J. P., Zijlstra, J. G., van der Werf, T. S., Kosterink, J. G. W., & Alffenaar, J. C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01607-13 · Cited by 29
Ramage, G. (2016) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000237 · Cited by 29
Kumar, D., Banerjee, T., Chakravarty, J., Sk, S., Dwivedi, A. K., & Tilak, R. (2016) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.188320 · Cited by 29
Fungal Biofilms in Human Disease
Williams, C., & Ramage, G. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-09782-4_2 · Cited by 29
DiMondi, V. P., Townsend, M. L., Johnson, M. D., & Durkin, M. J. (2014) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1433 · Cited by 28
Prabhakaran, V., Sengodan, T., & Rajeswari, P. (2016) · Current Medical Mycology · doi:10.18869/acadpub.cmm.2.2.3 · Cited by 28
Carter, J. E., Laurini, J. A., Evans, T. N., & Estrada, B. (2008) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2008.03.012 · Cited by 27
Actividad de la micafungina contra las biopelículas de Candida
Quindós, G., Villar-Vidal, M., & Eraso, E. (2009) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(09)70008-7 · Cited by 27
Silva-Dias, A., Miranda, I. M., Branco, J., Cobrado, L., Monteiro‐Soares, M., Pina‐Vaz, C., & Rodrigues, A. G. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku511 · Cited by 27
Fernandes, L., Fortes, B. N., Lincopán, N., & Ishida, K. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.573263 · Cited by 26
Virulence Factors and Azole-Resistant Mechanism of Candida Tropicalis Isolated from Candidemia
Sasani, E., Yadegari, M. H., Khodavaisy, S., Rezaie, S., Salehi, M., & Getso, M. I. (2021) · Mycopathologia · doi:10.1007/s11046-021-00580-y · Cited by 26
Is biofilm production a prognostic marker in adults with candidaemia?
Muñóz, P., Agnelli, C., Guinea, J., Vena, A., Álvarez-Uría, A., Marcos-Zambrano, L. J., Escribano, P., Valerio, M., & Bouza, E. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.022 · Cited by 26
Fujimoto, K., & Takemoto, K. (2018) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2018.08.011 · Cited by 24
Kawai, A., Yamagishi, Y., & Mikamo, H. (2015) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2015.05.007 · Cited by 23
“Candidemia is increasing gradually in recent clinical practices and is an important cause of mortality [1,2].”
BackgroundHou, Y., Yang, M., Li, J., Bi, X., Li, G., Xu, J., Xie, S., Dong, Y., Li, D., & Du, Y. (2020) · NanoImpact · doi:10.1016/j.impact.2020.100275 · Cited by 23
Cacaci, M., Squitieri, D., Palmieri, V., Torelli, R., Perini, G., Campolo, M., Vito, M. D., Papi, M., Posteraro, B., Sanguinetti, M., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16020275 · Cited by 23
Self-citationPires, R. H., Brugnera, M. F., Zanoni, M. V. B., & Mendes‐Giannini, M. J. S. (2015) · Applied Catalysis A General · doi:10.1016/j.apcata.2015.11.036 · Cited by 23
Curvelo, J. A. D. R., de Moraes, D. C., ANJOS, C. A. D., Portela, M. B., & Soares, R. M. A. (2019) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201920180045 · Cited by 23
Candidiasis asociada a biopelículas
del Pozo, J. L., & Cantón, E. (2015) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2015.06.004 · Cited by 24
Reiss, E., Lasker, B. A., Lott, T. J., Bendel, C. M., Kaufman, D. A., Hazen, K. C., Wade, K. C., McGowan, K. L., & Lockhart, S. R. (2012) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2012.06.012 · Cited by 23
Kischkel, B. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2022.tde-13102022-121545 · Cited by 23
Hamdy, R., Soliman, S. S. M., Alsaadi, A. I., Fayed, B. E., Hamoda, A. M., Elseginy, S. A., Husseiny, M. I., & Ibrahim, A. S. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105327 · Cited by 21
Miyazaki, T., & Kohno, S. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1058157 · Cited by 20
Kubešová, A., Šalplachta, J., Horká, M., Růžička, F., & Šlais, K. (2012) · The Analyst · doi:10.1039/c2an15931g · Cited by 20
Sadeghi, Z., Falahati, M., Fatemeh, R., Bahador, A., Alborzi, S. S., & Ashrafi‐Khozani, M. (2016) · Current Medical Mycology · doi:10.18869/acadpub.cmm.2.2.1 · Cited by 20
Anidulafungin for Candida glabrata Infective Endocarditis
Rosa, F. G. D., D’Avolio, A., Corcione, S., Baietto, L., Raviolo, S., Centofanti, P., Pasero, D., Rinaldi, M., & Perri, G. D. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00515-12 · Cited by 20
Antifungal and antibiofilm activities of chromones against nine Candida species
Lee, J., Kim, Y., Kim, Y., & Lee, J. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01737-23 · Cited by 19
Alvarez, L., Kumaran, K. S., Nitha, B., & Sivasubramani, K. (2024) · Brazilian Journal of Microbiology · doi:10.1007/s42770-024-01558-w · Cited by 19
Leveduras nos tratos urinário e respiratório: infecção fúngica ou não?
Vidigal, P. G., & Svidzinski, T. I. E. (2009) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.1590/s1676-24442009000100009 · Cited by 19
Wang, X., Liu, J., Chen, J., Zhang, M., Tian, C., Peng, X.-P., Li, G., Chang, W., & Lou, H. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104771 · Cited by 18
Lavaee, F., Badiei, P., Yousefi, M., & Haddadi, P. (2021) · Current Medical Mycology · doi:10.18502/cmm.6.4.5332 · Cited by 18
Delaney, C., Short, B., Rajendran, R., Kean, R., Burgess, K., Williams, C., Munro, C. A., & Ramage, G. (2023) · Biofilm · doi:10.1016/j.bioflm.2023.100112 · Cited by 18
Růžička, F., Horká, M., Holá, V., Kubešová, A., Pavlík, T., & Votava, M. (2010) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2010.01.007 · Cited by 18
Metadata
- Authors
- Tumbarello, M., Posteraro, B., Trecarichi, E. M., Fiori, B., Rossi, M., Porta, R., de Gaetano Donati, K., La Sorda, M., Spanu, T., Fadda, G., Cauda, R., & Sanguinetti, M.
- Affiliations
- Institutes of Infectious Diseases
- Università Cattolica del Sacro Cuore (IT)
- Microbiology, Università Cattolica del Sacro Cuore, Rome, Italy
- ORCID
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2007-06
- Volume
- 45
- Issue
- 6
- Pages
- 1843-1850
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC1933062
- OpenAlex
- W1976891952
- Cited by
- 343
- References
- 46
- Citations by year
- 2026: 15 · 2025: 9 · 2024: 9 · 2023: 12 · 2022: 12 · 2021: 23 · 2020: 21 · 2019: 14 · 2018: 19 · 2017: 27 · 2016: 25 · 2015: 20 · 2014: 23 · 2013: 24 · 2012: 22
- FWCI
- 9.86
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- candidemia, mortality risk factors, Candida albicans, Candida parapsilosis, Candida tropicalis, Candida glabrata, APACHE III score, nosocomial bloodstream infection, central venous catheters, antifungal susceptibility testing, Candida parapsilosis complex
- MeSH terms
- Aged, Antifungal Agents, Candida, Candidiasis, Female, Hospitals, University, Humans, Italy, Male, Microbial Sensitivity Tests, Middle Aged, Predictive Value of Tests, Risk Factors, Fungemia, Biofilms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.